Raynaud’s and Scleroderma

Upcoming Scleroderma Foundation Events

Two chapters of the Scleroderma Foundation have events in October that may be of interest to Raynaud’s sufferers: Scleroderma Foundation Delaware Valley Chapter is having a fundraiser walk in Philadelphia on October 14, 2012: http://is.gd/pyTYv3   Scleroderma Foundation / Tri-State […]

Apricus Biosciences Files for Orphan Drug Designation for RayVa(TM)

Drug Intended for the Treatment of Raynaud’s Phenomena, Secondary to Systemic Sclerosis   SAN DIEGO, April 13, 2011 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (“Apricus Bio”) (Nasdaq:APRI) announced today its filing with the U.S. Food & Drug Administration (“FDA”) requesting […]

Sildenafil (Viagra) Reduces Raynaud’s Frequency in Patients with Scleroderma

    Modified-Release Therapy is Well Tolerated in Clinical Trial Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The […]